Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Agrium (AGU) downgraded at BofA Merrill from Buy to Neutral. $99 price target. Macro uncertainty, deal risks offset fundamental strength.
Arthur J. Gallagher (AJG) upgraded at Brean from Hold to Buy. $35 price target. Company should see better rate momentum.Cisco Systems (CSCO) upgraded at Goldman to Buy. $21 price target. Street estimates may not be too conservative. Citrix Sytems (CTXS) upgraded at Morgan Stanley to Overweight. Stock is attractive, following a 24% decline since early June. $88 price target. Dow Chemical (DOW) upgraded at BofA Merrill from Underperform to Neutral. $42 price target. Solid guidance and strong risk/reward profile. The Gap (GPS) upgraded at Jefferies from Neutral to Buy. $25 price target. Valuation call as EPS expectations are low and sentiment negative. Hess (HES) downgraded at Deutsche Bank from Buy to Hold. $75 price target. Lack of significant near term catalysts. Intrepid Potash (IPI) upgraded at BofA Merrill from Neutral to Buy. $42 price target. Potash market set to strengthen, major catalysts at hand. Juniper (JNPR) downgraded at Citigroup from Buy to Hold. $27 price target. Weaker than expected results and long term growth remains cloudy. Lennox (LII) downgraded at UBS from Buy to Neutral. $38 price target. Lower visibility and revised outlook not clearly "beatable." ManTech (MANT) downgraded at Credit Suisse from Neutral to Underperform. $34 price target. Rising risk and uncertainty in the federal funding environment. Nextera Energy (NEE) downgraded at Baird to Neutral. Valuation call, based on a $59 price target. Varian Medical (VAR) downgraded at Baird to Neutral from Outperform, Robert Baird said. $72 price target. Company is seeing lower oncology orders. Varian Medical numbers lowered at Goldman. Shares of VAR now seen reaching $57, according to Goldman Sachs. Estimates also cut, as the company is realizing slower growth. Sell rating.
End of report.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV